Concepedia

Peter Barry

PB

Statistics

Publications

11

Citations

438

H-Index

11

Active since

1985

Affiliations

Manchester University NHS Foundation Trust(Current)

University of Manchester

Wythenshawe Hospital

Manchester Academic Health Science Centre

Peter Barry is an author at Manchester University NHS Foundation Trust specializing in medicine, ivacaftor therapy, and cystic fibrosis.

ORCID

Publications per year

1985–2023

11

Publications

11

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013)

Vito Amoroso, Daniele Generali, Thomas A. Buchholz et al. · JNCI Monographs · 2015 · 96 citations · Full text

, , +16

Effects of Ivacaftor in Patients With Cystic Fibrosis Who Carry the G551D Mutation and Have Severe Lung Disease

Peter Barry, Barry J. Plant, Arjun Nair et al. · CHEST Journal · 2014 · 92 citations

, , +16

Longitudinal effects of elexacaftor/tezacaftor/ivacaftor on liver tests at a large single adult cystic fibrosis centre

Daniel Tewkesbury, Varinder Athwal, R.J. Bright-Thomas et al. · Journal of Cystic Fibrosis · 2023 · 49 citations · Full text

, , +13

Reparative epiretinal fibrosis after diabetic vitrectomy.

Peter Barry, P. S. Hiscott, Ian Grierson et al. · PubMed · 1985 · 47 citations

, , +11

Longitudinal effects of ivacaftor and medicine possession ratio in people with the<i>Gly551Asp</i>mutation: a 5-year study

Ruth M. Mitchell, Andrew Jones, Katie Stocking et al. · Thorax · 2021 · 37 citations

, , +14

1–5 of 11